KCNK9 and cancer: Treatment of cells with more specific drugs indicated that the main pathway involved did not correspond to activation of two-pore K+ channels (TASK-3, TREK-1 and TREK-2), or to Ca2+-dependent K+ channels sensitive to apamin, some of which are proposed to be related to the cancer process in SKOV-3 cells17, 18.